Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in chinese male current smokers

Annals of Behavioral Medicine

Volumn 43, Issue 2, 2012, Pages 253-261

  Liu, Tao ^a   David, Sean P ^b   Tyndale, Rachel F ^c   Wang, Hui ^a   Yu, Xue Qing ^a   Chen, Wei ^a   Zhou, Qian ^c   Chen, Wei Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Center for Education in Family and Community Medicine   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Abdominal obesity; Cigarette smoking; CYP2A6 genotypes; Interaction

Indexed keywords

CYTOCHROME P 450 CYP1A6 (FISH); CYTOCHROME P-450 CYP1A6 (FISH); CYTOCHROME P450;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; ASIAN; CHINA; GENETIC ASSOCIATION; GENETICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MALE; MIDDLE AGED; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CYTOCHROME P-450 ENZYME SYSTEM; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; SMOKING;

EID: 84863728204     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-011-9318-5     Document Type: Article

References (51)

1. Prentice AM, Jebb SA: Beyond body mass index. Obes Rev 2001, 2: 141-147. (Pubitemid 33755907)
2. World Health Organization: Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894: i-xii, 1-253.
3. Corrada MM, Kawas CH, Mozaffar F, Paganini-Hill A: Association of body mass index and weight change with all-cause mortality in the elderly. Am J Epidemiol 2006, 163: 938-949.
4. Albanes D, Jones DY, Micozzi MS, Mattson ME: Associations between smoking and body weight in the US population: Analysis of NHANES II. Am J Public Health 1987, 77: 439-444. (Pubitemid 17044057)
5. Bamia C, Trichopoulou A, Lenas D, Trichopoulos D: Tobacco smoking in relation to body fat mass and distribution in a general population sample. Int J Obes Relat Metab Disord 2004, 28: 1091-1096. (Pubitemid 38998717)
6. Canoy D,Wareham N, Luben R,Welch A, Bingham S, Day N et al.: Cigarette smoking and fat distribution in 21,828 British men and women: A population-based study. Obes Res 2005, 13: 1466-1475.
7. Kannel WB, D'Agostino RB, Cobb JL: Effect of weight on cardiovascular disease. Am J Clin Nutr 1996, 63: 419S-422S. (Pubitemid 26075822)
8. Resnick HE, Valsania P, Halter JB, Lin X: Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health 2000, 54: 596-602. (Pubitemid 30460015)
9. U.S. Environmental Protection Agency, Office of Health and Environmental Assessment, 1992. Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. EPA/600/6-90/006F, pp 44-96.
10. Pasupathi P, Bakthavathsalam G, Rao YY, Farook J: Cigarette smoking-Effect of metabolic health risk: A review. Diabetes & Metabolic Syndrome 2009, 3: 120-127.
11. Tanko LB, Christiansen C: An update on the antiestrogenic effect of smoking: A literature review with implications for researchers and practitioners. Menopause 2004, 11: 104-109. (Pubitemid 40362206)
12. Sulander T, Rahkonen O, Nissinen A, Uutela A: Association of smoking status with obesity and diabetes among elderly people. Arch Gerontol Geriatr 2007, 45: 159-167. (Pubitemid 47087996)
13. Gilbert DG, Meliska CJ, Williams CL, Jensen RA: Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol. Psychopharmacology 1992, 106: 275-281.
14. Hukkanen J, Jacob P, Benowitz NL: Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005, 57: 79-115. (Pubitemid 40283970)
15. Nakajima M, Yokoi T: Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. Drug Metab Pharmacokinet 2005, 20: 227-235.
16. Mwenifumbo JC, Tyndale RF: Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics 2007, 8: 1385-1402. (Pubitemid 350162852)
17. Wang H, Qiu Q, Tan LL, Liu T, Deng XQ, Chen YM et al: Prevalence and determinants of diabetes and impaired fasting glucose among urban community-dwelling adults in Guangzhou, China. Diabetes Metab 2009, 35: 378-384.
18. Centers for Disease Control: National Health Interview Survey: Early release of selected estimates based on data from January to September 2007. Available at www.cdc.gov. Accessed 1 April 2011.
19. Wen W, Xiang YB, Zheng W, Xu WH, Yang G, Li H et al: The association of alcohol, tea, and other modifiable lifestyle factors with myocardial infarction and stroke in Chinese men. CVD Prev Control 2008, 3: 133-140.
20. Park MS, Chung SY, Chang Y, Kim K: Physical activity and physical fitness as predictors of all-cause mortality in Korean men. J Korean Med Sci 2009, 24: 13-9.
21. WHO/IASO/IOTF: The Asia-Pacific perspective: Redefining obesity and its treatment. Melbourne: Health Communications Australia. 2000.
22. Coorperative Meta-analysis Group of China Obesity Task Force: Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol 2002, 23: 5-10.
23. Lerman C, Jepson C, Wileyto EP, Patterson F, Schnoll R, Mroziewicz M et al: Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Clin Pharmacol Ther 2010, 87: 553-557.
24. Schoedel KA, Hoffmann EB, Rao Y, SellersEM, Tyndale RF: Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 2004, 14: 615-626. (Pubitemid 39281816)
25. Oscarson M, McLellan RA, Gullsten H, Agundez JA, Benitez J, Rautio A et al: Identification and characterisation of novel polymorphisms in the CYP2A locus: Implications for nicotine metabolism. FEBS Lett 1999, 460: 321-327. (Pubitemid 29495962)
26. Mwenifumbo JC, Myers MG, Wall TL, Lin SK, Sellers EM, Tyndale RF: Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method. Pharmacogenet Genomics 2005, 15: 189-192. (Pubitemid 40569906)
27. Fukami T, Nakajima M, Sakai H, McLeod HL, Yokoi T: CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele. Pharmacogenomics J 2006, 6: 401-412. (Pubitemid 44811536)
28. Ho MK, Mwenifumbo JC, Zhao B, Gillam EM, Tyndale RF: A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent. Pharmacogenet Genomics 2008, 18: 67-75. (Pubitemid 351161649)
29. Liu T, David SP, Tyndale RF, Wang H, Zhou Q, Ding P et al: Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction 2011, 105: 985-994
30. Rothman KJ, Greenland S, Lash TL: Modern epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia. 2008, 58.
31. Rose KM, Newman B, Mayer-Davis EJ, Selby JV: Genetic and behavioral determinants of waist-hip ratio and waist circumference in women twins. Obes Res 1998, 6: 383-392. (Pubitemid 128679687)
32. Troisi RJ, Heinold JW, Vokonas PS, Weiss ST: Cigarette smoking, dietary intake, and physical activity: Effects on body fat distribution-The Normative Aging Study. Am J Clin Nutr 1991, 53: 1104-1111.
33. Simon JA, Seeley DG, Lipschutz RC, Vittinghoff E, Browner WS: The relation of smoking to waist-To-hip ratio and diabetes mellitus among elderly women. Prev Med 1997, 26: 639-644.
34. Akbartabartoori M, Lean ME, Hankey CR: Relationships between cigarette smoking, body size and body shape. Int J Obes 2005, 29: 236-243. (Pubitemid 40188421)
35. ShimokataH,MullerDC, Andres R: Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 1989, 261: 1169-1173. (Pubitemid 19062452)
36. Mizuno O, Okamoto K, Sawada M, Mimura M, Watanabe T, Morishita T: Obesity and smoking: Relationship with waist circumference and obesity-related disorders in men undergoing a health screening. J Atheroscler Thromb 2005, 12: 199-204.
37. Molenaar EA, Massaro JM, Jacques PF, Pou KM, Ellison RC, Hoffmann K et al: Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: The Framingham Heart Study. Diabetes Care 2009, 32: 505-510.
38. Hideaki K, Yutaka M, Takuo YTN: Smoking as a Risk Factor for Visceral Fat Accumulation in Japanese Men. Tohoku J Exp Med 2006, 208: 123-132.
39. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J: Active smoking and the risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2007, 298: 2654-2664. (Pubitemid 350254957)
40. Koh-Banerjee P, Chu NF, Spiegelman D, Rosner B, Colditz G, Willett Wet al: Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. Am J Clin Nutr 2003, 78: 719-727. (Pubitemid 39663489)
41. Rossini A, de Almeida Simao T, Albano RM, Pinto LF: CYP2A6 polymorphisms and risk for tobacco-related cancers. Pharmacogenomics 2008, 9: 1737-1752.
42. Pianezza ML, Sellers EM, Tyndale RF: Nicotine metabolism defect reduces smoking. Nature 1998, 393: 750. (Pubitemid 28299478)
43. Tyndale RF, Sellers EM: Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Ther Drug Monit 2002, 24: 163-171. (Pubitemid 34106747)
44. Kamataki T, Fujieda M, Kiyotani K, Iwano S, Kunitoh H: Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk. Biochem Biophys Res Commun 2005, 338: 306-310. (Pubitemid 41540571)
45. Fujieda M, Yamazaki H, Saito T, Kiyotani K, Gyamfi MA, Sakurai M et al: Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis 2004, 25: 2451-2458. (Pubitemid 39625186)
46. Derby KS, Cuthrell K, Caberto C, Carmella SG, Franke AA, Hecht SS et al: Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer. Cancer Epidemiol Biomarkers Prev 2008, 17: 3526-3535.
47. Tiwawech D, Srivatanakul P, Karalak A, Ishida T: Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. Cancer Lett 2006, 241: 135-141.
48. Kadlubar S, Anderson JP, Sweeney C, Gross MD, Lang NP, Kadlubar FF et al: Phenotypic CYP2A6 variation and the risk of pancreatic cancer. JOP 2009, 10: 263-270.
49. Song DK, Xing DL, Zhang LR, Li ZX, Liu J, Qiao BP: Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detect Prev 2009, 32: 416-423.
50. Ruwali M, Pant MC, Shah PP, Mishra BN, Parmar D: Polymorphism in cytochrome P450 2A6 and glutathione S-Transferase P1 modifies head and neck cancer risk and treatment outcome. Mutat Res 2009, 669: 36-41.
51. Nakajima M, Kuroiwa Y, Yokoi T: Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6. Drug Metab Rev 2002, 34: 865-877.